CYP1B1-catalyzed 4-OHE2 promotes the castration resistance of prostate cancer stem cells by estrogen receptor α-mediated IL6 activation

BACKGROUND: Resistance to androgen deprivation therapy remains a major challenge for the clinical treatment of patients with castration-resistant prostate cancer (CRPC). CYP1B1, a critical enzyme that catalyzes the conversion of estradiol to 4-Hydroxy-17β-estradiol (4-OHE2), has been reported to pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Qimei, Cao, Jiasong, Du, Xiaoling, Yang, Kuo, Yang, Xu, Liang, Zhixian, Shi, Jiandang, Zhang, Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922936/
https://www.ncbi.nlm.nih.gov/pubmed/35292057
http://dx.doi.org/10.1186/s12964-021-00807-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922936/
https://www.ncbi.nlm.nih.gov/pubmed/35292057
http://dx.doi.org/10.1186/s12964-021-00807-x

Ejemplares similares